Glenohumeral Cortisone Injection

University of Washington9 enrolled

Overview

The objective of this project is to determine if giving a cortisone injection to patients with proximal humerus fractures who have stiff shoulders recover their range of motion.

THis is a randomized control trial to determine if giving a cortisone injection to patients with proximal humerus fractures who have stiff shoulders recover their range of motion.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Humeral Fractures

Interventions

kenalogDRUG

Cortisone injection into shoulder

LidocaineDRUG

Lidocaine injection into shoulder

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1.18-90 2\. Proximal Humerus Fracture 3\. Decreased range of motion at 6 wk follow-up 4\. Likely to be available for follow up for 26 wks Exclusion Criteria: 1. Known drug allergy to kenalog or lidocaine 2. Unable to complete functional outcome 3. Pregnant Women

Locations (1)

University of Washington

Seattle, Washington, United States

Outcomes

Primary Outcomes

American Shoulder Elbow Society Score

Outcome Instrument high is good low is bad 0-100 The ASES is a condition-specific scale that is intended to measure functional limitations and pain of the shoulder.

Time frame: 24 weeks

Secondary Outcomes

Visual Analogue Scale

pain scale - high is bad - low is good 0-100

Time frame: 24 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.